BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 15448739)

  • 1. Nitric oxide and platelet energy metabolism.
    Tomasiak M; Stelmach H; Rusak T; Wysocka J
    Acta Biochim Pol; 2004; 51(3):789-803. PubMed ID: 15448739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxynitrite can affect platelet responses by inhibiting energy production.
    Rusak T; Tomasiak M; Ciborowski M
    Acta Biochim Pol; 2006; 53(4):769-76. PubMed ID: 17068635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
    Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
    Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cyanide and nitric oxide with cytochrome c oxidase: implications for acute cyanide toxicity.
    Leavesley HB; Li L; Prabhakaran K; Borowitz JL; Isom GE
    Toxicol Sci; 2008 Jan; 101(1):101-11. PubMed ID: 17906319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.
    Martinez A; Salas E; Radomski A; Radomski MW
    Med Sci Monit; 2001; 7(4):646-51. PubMed ID: 11433190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of aspartate aminotransferase for platelet aggregation.
    Tomasiak M
    Haematologia (Budap); 1986; 19(2):101-12. PubMed ID: 3758838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.
    Cassina A; Radi R
    Arch Biochem Biophys; 1996 Apr; 328(2):309-16. PubMed ID: 8645009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
    Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
    J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo.
    Ng SS; Pang CC
    Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac mitochondrial cGMP stimulates cytochrome c release.
    Seya K; Motomura S; Furukawa K
    Clin Sci (Lond); 2007 Jan; 112(2):113-21. PubMed ID: 16961461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NO-donors, part 9 : diazeniumdiolates inhibit human platelet aggregation and induce a transient vasodilatation of porcine pulmonary arteries in accordance with the NO-releasing rates.
    Abuo-Rahma Gel D; Horstmann A; Radwan MF; El-Emam A; Glusa E; Lehmann J
    Eur J Med Chem; 2005 Mar; 40(3):281-7. PubMed ID: 15725497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation.
    Gudmundsdóttir IJ; McRobbie SJ; Robinson SD; Newby DE; Megson IL
    Biochem Biophys Res Commun; 2005 Nov; 337(1):382-5. PubMed ID: 16185664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
    Judge S; Mammen E; Dunbar JC
    J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide inhibits succinate dehydrogenase-driven oxygen consumption in potato tuber mitochondria in an oxygen tension-independent manner.
    Simonin V; Galina A
    Biochem J; 2013 Jan; 449(1):263-73. PubMed ID: 23039043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet adhesion to collagen by cGMP-elevating agents.
    Wu CC; Ko FN; Teng CM
    Biochem Biophys Res Commun; 1997 Feb; 231(2):412-6. PubMed ID: 9070290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.